Pfizer has begun work on a state of the art facility in Kano, Nigeria.
Multinational drug firm Pfizer has begun work on a state-of-the-art medical facility in Kano, Nigeria. The hospital, which will cost about $30 million, follows a 1996 Trovan drug test out of court settlement between the government of Kano State and Pfizer Incorporated.
Laying the foundation of the new facility, State Governor Mallam Ibrahim Shekarau said the move by the world’s largest pharmaceutical company, will boost the health care delivery in the state and also conveyed the company’s commitment to ensuring the wellbeing of Nigerians.
Shekarau also passingly touched on the tragedy that unfolded when hundreds of people died or took ill in Kano after being administered by the drug in a surreptitious test conducted by Pfizer undertaken to test the drug’s efficacy and effects. The company, which was later sued by the state and the federal government, had then reached an out-of-court settlement with the two parties.
Speaking on the new facility construction, Chris Loder, spokesperson for Pfizer, said: “The construction of a new state of the art medical centre in Kano is proof positive that Pfizer continues to fulfil its commitments to Nigeria and its people. This event allows the company to further its work on what really matters – improving the healthcare for all Nigerians.”
Equipped with a centre for disease control, a public health laboratory, a diagnostic centre, a micro-biological reference laboratory and residence staff quarters, Pfizer’s new effort has come as some relief for many local people, particularly victims of the 1996 test.
This is a good investment both for Pfizer and Nigeria. Pfizer gets to develop, build it’s brand in Africa’s most populus nation, which economically has yet to reach its apex and Nigeria gets the upside of foreign direct investment with a state of the art facility.